Developer of small-molecule inhibitors designed to treat cardiometabolic diseases and cancer. The company's therapies block a key enzyme in the retinoid and rexinoid nuclear receptor pathways, disrupt...

Healthcare
Seattle, WA, United States
Founded 2018
6 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$20.9M
Last Round
N/A

Get the full picture

Create a free account to unlock KayoThera's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required